CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRIN) — FDA Approval ANDA210719 (P
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRIN) — FDA Approval ANDA210719 (P is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE; Active ingredients: CETIRIZINE HYDROCHLORI
| Brand name | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE |
|---|---|
| Active ingredients | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Application number | ANDA210719 |
| Sponsor | PPI-DAC |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Over-the-counter |
| Products in application | 1 |
| First approval date | 20181116 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →